Pharmacokinetics of High-Dose Methotrexate in Egyptian Children with Acute Lymphoblastic Leukemia: Impact of Interpatient Variations
Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2015, Vol 5, Issue 10
Abstract
Aim:Since several factors have been shown to influence the clearance of methotrexate, the purpose of this study was to identify potential relationships between patient covariates and the methotrexate clearance estimates and deduce a pharmacokinetic model for the estimation of methotrexate clearance in Egyptian pediatric ALL patients that may help dosage adjustment and achieve target steady-state plasma concentrations in a similar sittings. Patients and methods: A total of 94 pediatric patients with B-cell ALL, of whom 70 were the studied population and 24 were the test population, were treated with four courses of HDMTX doses 2.5 gm/m2 (low-risk arm) or 5 gm/m2 (standard-/high-risk arm) given every other week by intermittent intravenous infusions over 24 hours as a part of their treatment protocol. Patients were monitored for the 24 hour MTX concentration and the systemic methotrexate clearance was calculated for each methotrexate dose. Results:The studied patients had average age of 7.1 ± 4.44 years; total body weight of 30.3 ± 21.04 kg, average height of 117.63 ± 28.09 cm, body surface area of 0.97 ± 0.45 m2 and body mass index of 19.25 ± 4.49. The average creatinine clearance calculated using Schwartz formula was 167.83 ± 48.44 ml/min. The mean methotrexate clearance was 7.83 ± 4.52 L/hr. Estimated creatinine clearance and body mass index were identified as the most important factors influencing methotrexate clearance in the studied patients. Conclusion:A Pharmacokinetic model was proposed to estimate the individual methotrexate clearance for Egyptian pediatric ALL patients. The derived final regression model reasonably predicted clearance values with best fitness and precessions
Authors and Affiliations
Abdel-Hameed I. M. Ebid1,Mohamed A. M. Ibrahim1 , Sameera Ezzat2
Keywords
Related Articles
- EP ID EP101094
- DOI -
- Views 120
- Downloads 0
Helicobacter Pylori- Factors of Virulence and Persistence: The Ability to Colonise the Human Stomach for Extended Periods Despite Host Immune and Inflammatory Responses.
Helicobacter pylori is perhaps the most prevalent and successful human pathogen worldwide. Since it was initially suggested in 1983 by Marshall and Warren to be implicated in gastritis and peptic ulcer disease, H...
Implementation of Drugs & Cosmetics Act 1940 and Rules Thereunder In Odessa: An Overview
Odishahas been one of the Eastern State of India.Drugs Regulation in Indiais governed by the Drugs and Cosmetics Act, 1940 and it has been the focus of several recent policy reforms efforts in India, starting withMashela...
Who are the Smokers and what Factors Influence Smoking among Amassoma Community in South-South Nigeria?
ma Community in South-South Nigeria. Questionnaires were administered randomly within the community to 260 consenting respondents; Data was analyzed with SPSS version 20. Respondents were Males (73.6%), aged...
Comparitive study of nimodipine versus Nifedipine in the treatment of hyperstion in pregnancy
Hypertensive disorders of pregnancy complicates about 7-10% pregnancy. Various anti-hypertensives have been tried to control the pressure without much affecting the maternal and fetal health. The present study, com...
Prophylactic magnesium sulphate in severe preeclampsia- Loading dose only vs. conventional 24 hour therapy of modified Pritchard's regime- A randomised trial.
Objective: To determine the efficacy and safety of only the loading dose of modified Pritchard's regime of magnesium sulphate therapy in patients of severe preeclampsia. Method: Patients of severe preeclampsia...